Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.
Rubbia-Brandt
Laura
L
Mentha
Gilles
G
Terris
Benoit
B
D000970:Antineoplastic Agents / Q000009:adverse effects*; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D003937:Diagnosis, Differential; D005234:Fatty Liver / Q000139:chemically induced* / Q000175:diagnosis; D006504:Hepatic Veno-Occlusive Disease / Q000139:chemically induced* / Q000175:diagnosis; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary* / Q000601:surgery; D009944:Organoplatinum Compounds / Q000009:adverse effects*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin